MDxHealth (MDXH) Net Income towards Common Stockholders (2021 - 2025)
Historic Net Income towards Common Stockholders for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to -$8.0 million.
- MDxHealth's Net Income towards Common Stockholders rose 2368.0% to -$8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.1 million, marking a year-over-year increase of 2470.19%. This contributed to the annual value of -$38.1 million for FY2024, which is 1167.29% up from last year.
- Per MDxHealth's latest filing, its Net Income towards Common Stockholders stood at -$8.0 million for Q3 2025, which was up 2368.0% from -$7.4 million recorded in Q2 2025.
- In the past 5 years, MDxHealth's Net Income towards Common Stockholders ranged from a high of -$6.7 million in Q4 2024 and a low of -$18.1 billion during Q2 2022
- Its 5-year average for Net Income towards Common Stockholders is -$1.1 billion, with a median of -$10.0 million in 2023.
- As far as peak fluctuations go, MDxHealth's Net Income towards Common Stockholders crashed by 9366.22% in 2022, and later skyrocketed by 9994.13% in 2023.
- MDxHealth's Net Income towards Common Stockholders (Quarter) stood at -$8.1 million in 2021, then tumbled by 50.73% to -$12.2 million in 2022, then rose by 12.02% to -$10.7 million in 2023, then surged by 37.07% to -$6.7 million in 2024, then decreased by 18.93% to -$8.0 million in 2025.
- Its last three reported values are -$8.0 million in Q3 2025, -$7.4 million for Q2 2025, and -$8.9 million during Q1 2025.